SCHEMBL7014633

SCHEMBL7014633

COC(=O)C1=C(C)Nc2ccn(CC#N)c(=O)c2C1c1ccc(F)c(Br)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC9 O60706 7/20 0.52
ABCC8 Q09428 7/20 0.52
KCNJ11 Q14654 7/20 0.52
KCNJ8 Q15842 7/20 0.52
LMNA P02545 1/20 0.48
TSHR P16473 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HPGD P15428 2/20 0.39
GAA P10253 3/20 0.38
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PDE1C Q14123 1/20 0.37
ADRA1D P25100 2/20 0.37
ADRA1A P35348 2/20 0.37
ADRA1B P35368 2/20 0.37
HTT P42858 1/20 0.36
CACNA1F O60840 2/20 0.36
CACNA1D Q01668 2/20 0.36
CACNA1S Q13698 2/20 0.36
CACNA1C Q13936 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7015302 0.85 ABCC9 (0.52) ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL7573282 0.79 ABCC9 (0.57) ABCC9ABCC8KCNJ11KCNJ8LMNA
SCHEMBL7099447 0.73 ABCC9 (0.55) ABCC9ABCC8KCNJ11KCNJ8LMNA
SCHEMBL6925767 0.72 ABCC9 (0.66) ABCC9ABCC8KCNJ11KCNJ8LMNA
SCHEMBL7662609 0.71 ABCC9 (0.65) ABCC9ABCC8KCNJ11KCNJ8LMNA
SCHEMBL7573252 0.71 ABCC9 (0.55) ABCC9ABCC8KCNJ11KCNJ8LMNA
SCHEMBL7101463 0.71 ABCC9 (0.64) ABCC9ABCC8KCNJ11KCNJ8HPGD
SCHEMBL5075485 0.70 ABCC9 (0.68) ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL7575450 0.70 ABCC9 (0.63) ABCC9ABCC8KCNJ11KCNJ8LMNA
SCHEMBL5075369 0.69 ABCC9 (0.53) ABCC9ABCC8KCNJ11KCNJ8LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1307453-A2 DIHYDRONAPHTHYRIDINE- AND DIHYDROPYRROLOPYRIDINE-DERIVATED COMPOUNDS AS POTASSIUM CHANNEL OPENERS ABBOTT LABORATORIES (US) 2003-05-07 EP disclosed
US-20020099070-A1 Dihydronaphthyridine potassium channel openers ABBOTT LABORATORIES 2002-07-25 US disclosed
WO-2002010164-A2 DIHYDRONAPHTHYRIDINE- AND DIHYDROPYRROLOPYRIDINE-DERIVATED COMPOUNDS AS POTASSIUM CHANNEL OPENERS ABBOTT LABORATORIES (US) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020099070-A1 Dihydronaphthyridine potassium channel openers KCNH1, KCNN1, KCNJ2 ABCC9 440/4885ABCC8 645/4885KCNJ11 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.